Navigation Links
Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements
Date:6/2/2008

xample newly diagnosed, is scheduled to start in 2009," explains Dr. Karl-Hermann Schlingensiepen, Chief Executive Officer of Antisense Pharma.

Literature

(1) Bogdahn, U. et al. "Results of a Phase IIb Active-controlled Study with AP 12009 for Patients with Recurrent or Refractory Anaplastic Astrocytoma", ASCO Annual Meeting, 2008, Abstract ID 2076

(2) Bogdahn, U. et al. "Targeted Therapy with AP 12009 in Recurrent or Refractory Glioblastoma Patients: Results of a Phase IIb Study", ASCO Annual Meeting, 2008, Abstract ID 2018

The Phase IIb study AP 12009-G004

The Phase IIb study AP 12009-G004 is an open-label, randomized, active-controlled, parallel-group dose-finding study to evaluate the efficacy and safety of two doses of AP 12009 in adult patients with recurrent or refractory high-grade glioma. Efficacy endpoints were tumor response assessed by central blinded MRI reading and survival. At 29 international clinical centers, 134 evaluable patients (39 with anaplastic astrocytoma, AA, WHO grade III and 95 with glioblastoma, GBM, WHO grade IV) have been randomized to three arms: AP 12009 10 mM, AP 12009 80 mM and standard chemotherapy (Temozolomide or PCV) as an active control. AP 12009 was administered intratumorally via one catheter as continuous high-flow microperfusion over a 7-day period every other week for up to 6 months on an outpatient treatment basis. Tumor response was assessed according to Macdonald criteria. Post-study follow-up for survival, long-term tumor response, and safety is still ongoing. Analysis of the core phase is completed.

High-Grade Glioma

Anaplastic astrocytoma and glioblastoma are the two most common forms of primary brain tumors, a diagnosis with high unmet medical need. Adults as well as children may be affected, although the age peak is at 45-65 years. Current therapies comprise surgery, radiation and/or chemotherapy. Despite recent advances, the prognosis for these patients is still po
'/>"/>

SOURCE Antisense Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
2. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
3. New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
4. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
5. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
6. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
7. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
8. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
9. Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
10. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
11. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Decision Resources Group finds ... the U.S. Food and Drug Administration,s (FDA) approval of ... Velphoro, which was approved by the FDA in November ... disease (CKD) patients on dialysis. Other key ... (US) Q2 2014 : ...
(Date:1/15/2014)... Jan. 15, 2014 Most osteoporosis patients want a ... recent online survey* sponsored by Mission Pharmacal Company. The ... Osteoporosis Foundation online support community, revealed that 74 percent ... comes in a form other than a pill or ...
(Date:1/15/2014)... 15, 2014 AARP Foundation today announced it has established ... from the severe cold weather that has gripped much of ... those in need; so to support these emergency relief efforts ... $250,000, which could mean up to $500,000 in aid. The ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... N.J., Oct. 30 Novo Nordisk Inc. announced the ... hemophilia(TM) campaign through a rebranded Web site and ... face many daily challenges, and Novo Nordisk is committed ... a lifetime of possibilities. , These new online resources ...
... GUANGZHOU, China, Oct. 30 ... CHME) ("China Medicine" or "the Company"), a ... pharmaceuticals,traditional Chinese medicines ("TCM"), nutritional and dietary ... announced that through its,wholly-owned subsidiary in China, ...
Cached Medicine Technology:Novo Nordisk is Changing Possibilities in Hemophilia 2Novo Nordisk is Changing Possibilities in Hemophilia 3China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 2China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 3China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 4
(Date:7/11/2014)... 11, 2014 Utilizing the Keller Funnel, ... William Koenig, has topped a record number of complication-free ... performed over 400 successful procedures without the occurrence of ... well known across the country for his expertise with ... has long been the foundation for numerous studies and ...
(Date:7/11/2014)... Ticket Down is a reliable source ... When it comes to the summer concert schedule, it just ... native is one of the biggest names in country music and ... currently out on his “That’s My Kind of Night” tour featuring ... will be making through the rest of the summer and into ...
(Date:7/11/2014)... are widely applied in turf and ornamentals. They enhance ... turf and ornamentals in absorption of water, nutrient uptake, ... appear healthy and strong as a result of using ... few years. The most dominating region in biostimulants markets ... share in 2013, and is estimated to grow at ...
(Date:7/11/2014)... PULLMAN, Wash.The largest study of its kind has ... suite of advantages over their conventional counterparts, including ... , The study looked at an unprecedented 343 ... of organic and conventional plant-based foods, including fruits, ... meta-analysis techniques to quantify differences between organic and ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap Luke ... Over the years Luke Bryan has been honored by almost every ... well at award shows, but each summer, he hits the road ... the genre and this summer is more of the same. When ... popularity and success that is currently entitled to Luke Bryan. The ...
Breaking Medicine News(10 mins):Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3
... complaints show it may not be for everyone , , FRIDAY, ... vision-correcting LASIK surgery as "life changing." NASA now allows astronauts ... has been performed on 112,500 military personnel, including pilots. ... this elective surgery being lost in this laudatory celebration? ...
... of Deep Brain Stimulation, or ,Brain,Pacemakers, on the ... WASHINGTON, April 25 The U.S. Department ... are teaming up to,raise awareness about deep brain ... disorders and disabilities., HHS, Office on Disability ...
... Leinbach, a,9-year-old student in Mrs. Sheri Fetterhoff,s ... County, will receive a $1,000,educational bond for ... 2008 National Children,s Dental Health Month (NCDHM),statewide ... reproduced as bookmarks, which will be,distributed to ...
... The United States,Agency for International Development (USAID) is ... solution that reduces the risk of,diarrhea. Sur,Eau is ... chlorine solution can be added to water immediately ... principally young children and,people living with HIV and ...
... April 25 The Michigan,Chamber of Commerce today announced ... find its way to the November 2008 ballot and,constitutionally ... care system. The Michigan Chamber cited serious concerns with ... and the fact,that Michigan job providers and taxpayers would ...
... 25 SynergEyes, Inc., of Carlsbad, CA,recently launched ... need further vision correction after undergoing refractive vision,surgery. ... who,have experienced some type of corneal trauma or ... millions of people undergo LASIK or other types ...
Cached Medicine News:Health News:FDA Panel Urges Stronger Warnings for LASIK Surgery 2Health News:FDA Panel Urges Stronger Warnings for LASIK Surgery 3Health News:FDA Panel Urges Stronger Warnings for LASIK Surgery 4Health News:HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders 2Health News:HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders 3Health News:Pennsylvania Dental Association Announces Winners of Annual Statewide Third-grade Student Poster Contest 2Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:Michigan Chamber of Commerce Opposes 'Blank Check' Healthcare Ballot Proposal 2Health News:SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients 2
Double ended with 0.5 mm x 10 mm and 0.5 mm x 15 mm blades. Both blades gently curved. Square serrated handle with polished finish. Most popular size or model....
11 mm angled tip with gently curved blade. Flat serrated handle with polished finish....
Angled tip with gently curved blade. Short hexagonal handle with polished finish. 0.5 mm x 15 mm tip....
Double ended with 0.5 mm by 10 mm and 0.5 mm by 15 mm blades. Both ends are sharp with gently curved blades. Square serrated handle with polished finish. Most popular size or model....
Medicine Products: